These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38936518)

  • 61. Diurnal control of iron responsive element containing mRNAs through iron regulatory proteins IRP1 and IRP2 is mediated by feeding rhythms.
    Nadimpalli HP; Katsioudi G; Arpa ES; Chikhaoui L; Arpat AB; Liechti A; Palais G; Tessmer C; Hofmann I; Galy B; Gatfield D
    Genome Biol; 2024 May; 25(1):128. PubMed ID: 38773499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development.
    Smith SR; Ghosh MC; Ollivierre-Wilson H; Hang Tong W; Rouault TA
    Blood Cells Mol Dis; 2006; 36(2):283-7. PubMed ID: 16480904
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
    Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
    J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.
    Berg D; Hochstrasser H; Schweitzer KJ; Riess O
    Neurotox Res; 2006 Jan; 9(1):1-13. PubMed ID: 16464747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies.
    Smith SR; Cooperman S; Lavaute T; Tresser N; Ghosh M; Meyron-Holtz E; Land W; Ollivierre H; Jortner B; Switzer R; Messing A; Rouault TA
    Ann N Y Acad Sci; 2004 Mar; 1012():65-83. PubMed ID: 15105256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuronal nitric oxide synthase phosphorylation induced by docosahexaenoic acid protects dopaminergic neurons in an experimental model of Parkinson's disease.
    Parlak H; Ozkan A; Dilmac S; Tanriover G; Ozsoy O; Agar A
    Folia Histochem Cytobiol; 2018; 56(1):27-37. PubMed ID: 29577226
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Manganese overexposure results in ferroptosis through the HIF-1α/p53/SLC7A11 pathway in ICR mouse brain and PC12 cells.
    Chen J; Tao Z; Zhang X; Hu J; Wang S; Xing G; Ngeng NA; Malik A; Appiah-Kubi K; Farina M; Skalny AV; Tinkov A; Aschner M; Yang B; Lu R
    Ecotoxicol Environ Saf; 2024 Jul; 279():116481. PubMed ID: 38788562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Angiotensin II-induced vascular endothelial cells ferroptosis via P53-ALOX12 signal axis.
    Liu C; Shen Y; Cavdar O; Huang J; Fang H
    Clin Exp Hypertens; 2023 Dec; 45(1):2180019. PubMed ID: 36860117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Possible involvement of iron-induced oxidative insults in neurodegeneration.
    Asano T; Koike M; Sakata S; Takeda Y; Nakagawa T; Hatano T; Ohashi S; Funayama M; Yoshimi K; Asanuma M; Toyokuni S; Mochizuki H; Uchiyama Y; Hattori N; Iwai K
    Neurosci Lett; 2015 Feb; 588():29-35. PubMed ID: 25549542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Zheng Q; Ma P; Yang P; Zhai S; He M; Zhang X; Tu Q; Jiao L; Ye L; Feng Z; Zhang C
    Neurosci Lett; 2023 Jul; 810():137346. PubMed ID: 37308056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clozapine-N-oxide protects dopaminergic neurons against rotenone-induced neurotoxicity by preventing ferritinophagy-mediated ferroptosis.
    Sun Q; Wang Y; Hou L; Li S; Hong JS; Wang Q; Zhao J
    Free Radic Biol Med; 2024 Feb; 212():384-402. PubMed ID: 38182072
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model.
    Xia Y; Wang H; Xie Z; Liu ZH; Wang HL
    Free Radic Biol Med; 2024 Feb; 211():63-76. PubMed ID: 38092273
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.
    Ghosh MC; Zhang DL; Rouault TA
    Neurobiol Dis; 2015 Sep; 81():66-75. PubMed ID: 25771171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Silent information regulator sirtuin 1 ameliorates acute liver failure
    Zhou XN; Zhang Q; Peng H; Qin YJ; Liu YH; Wang L; Cheng ML; Luo XH; Li H
    World J Gastroenterol; 2024 Mar; 30(11):1588-1608. PubMed ID: 38617450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ferroptosis in Parkinson's disease: glia-neuron crosstalk.
    Wang ZL; Yuan L; Li W; Li JY
    Trends Mol Med; 2022 Apr; 28(4):258-269. PubMed ID: 35260343
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Association of Iron and the Pathologies of Parkinson's Diseases in MPTP/MPP
    Shi L; Huang C; Luo Q; Rogers E; Xia Y; Liu W; Ma W; Zeng W; Gong L; Fang J; Tang L; Cheng A; Shi R; Chen Z
    Front Aging Neurosci; 2019; 11():215. PubMed ID: 31543809
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
    Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
    J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protective Effects of Querectin against MPP
    Jiang Y; Xie G; Alimujiang A; Xie H; Yang W; Yin F; Huang D
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):42. PubMed ID: 37005755
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.
    Hang W; Fan HJ; Li YR; Xiao Q; Jia L; Song LJ; Gao Y; Jin XM; Xiao BG; Yu JZ; Ma CG; Chai Z
    Metab Brain Dis; 2022 Jun; 37(5):1435-1450. PubMed ID: 35488941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.